Toggle sidebar
Toggle sidebar
全部
智能回答
Search
Search
定价
登录
Company growth focus in 2026
搜索文档
Geron signals 2026 growth focus as RYTELO new patient starts rise to 36% in Q3 (NASDAQ:GERN)
Seeking Alpha
·
2025-11-06 03:21
技术访问问题 - 为确保未来正常访问 需在浏览器中启用Javascript和cookies [1] - 启用广告拦截器可能导致访问受阻 需禁用广告拦截器并刷新页面 [1]
杰龙(US:GERN)
Company growth focus in 2026
RYTELO
Company growth focus in 2026
RYTELO